Within Americas could soon see much larger companies interested in their potential...despite the patent deal at �15m the product range and global reach will seem a snip to some.
Will increasingly leave employers open to our "Blame / Claim " society......... Increasingly Trak will see take up to minimise employer risks IMHO ..........http://think.direct.gov.uk/fatigue.html
In this format will force the hand of the parties seeking partnerships. The March presentation indicated the bigger picture linked with the condom products. Notice the statement that if partners wish to introduce the 0.8 formulation they could at their own cost......... Pain has been place on the announcement to state ease of trial and reduced costs..... All again negotiation standpoint that say if your not in we can do this alone! Makes me think the speed and content of the RNS is not just for the shareholders
But TRAK seem to have upped their game with the advertising to SME's with their recent campaign. Think the SAAS tipping point is about 325 k units on current cost base..... Would predict second half will see the recent investment starting to pay for itself..... With a potential substantial re-rate